Autophagy: Healthy eating and self-digestion for gastroenterologists

Journal of Pediatric Gastroenterology and Nutrition

Volumn 46, Issue 5, 2008, Pages 496-506

  Hussey, Séamus ^a,b,c   Terebiznik, Mauricio R ^c   Jones, Nicola L ^a,b,c  

^a Division of Gastroenterology   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autophagy; Cancer; Crohn disease; Innate immunity; Microbial pathogenesis

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ADAPTIVE IMMUNITY; ALPHA 1 ANTITRYPSIN DEFICIENCY; APOPTOSIS; AUTOPHAGY; AUTOPHAGY GENE; BIOGENESIS; CARCINOGENESIS; CELL PROTECTION; CROHN DISEASE; CYTOLOGY; DIGESTION; DIGESTIVE SYSTEM CANCER; DISEASE PREDISPOSITION; DISORDERS OF PEROXISOMAL FUNCTIONS; EMBRYO DEVELOPMENT; ENDOSOME; ENTEROPATHY; EUKARYOTIC CELL; FEEDING BEHAVIOR; FETUS DEVELOPMENT; GENE; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; INTESTINE BRUSH BORDER; LYSOSOME; LYSOSOME STORAGE DISEASE; MICROVILLUS INCLUSION DISEASE; MUTATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; CELL AGING; CELL DEATH; GASTROINTESTINAL DISEASE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT;

EUKARYOTA;

AUTOPHAGY; CELL AGING; CELL DEATH; EUKARYOTIC CELLS; GASTROINTESTINAL DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROTEIN TRANSPORT;

EID: 48249134790     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181617895     Document Type: Review

References (130)

1. Assuncao Guimaraes C, Linden R. Programmed cell deaths: apop-tosis and alternative deathstyles. Eur J Biochem 2004;271:1638-50.
2. Finn PF, Dice JF Proteolytic and lipolytic responses to starvation. Nutrition 2006;22:830-44.
3. Cuervo AM, Palmer A, Rivett AJ, et al. Degradation of proteasomes by lysosomes in rat liver. Eur J Biochem 1995;227:792-800.
4. Ding WX, Ni HM, Gao W, et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 2007; 171:513-24.
5. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004;6:463-77.
6. Mijaljica D, Prescott M, Devenish RJ. Endoplasmic reticulum and Golgi complex: contributions to, and turnover by, autophagy. Traffic 2006;7:1590-5.
7. Maiuri MC, Zalckvar E, Kimchi A, et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007;8:741-52.
8. Xiao G. Autophagy and NF-kappaB: fight for fate. Cytokine Growth Factor Rev 2007;18:233-43.
9. Ueno T, Muno D, Kominami E. Membrane markers of endoplasmic reticulum preserved in autophagic vacuolar membranes isolated from leupeptin-administered rat liver. J Biol Chem 1991;266:18995-9.
10. Dunn WA Jr. Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol 1990;110:1923-33.
11. Klionsky DJ, Cregg JM, Dunn WA Jr, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003;5:539-45.
12. Tanida I, Ueno T, Kominami E. Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met 121 to expose Gly 120 for lipidation and targeting to autophagosomal membranes. J Biol Chem 2004;279:47704-10.
13. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. Embo J 2000;19:5720-8.
14. Ichimura Y, Kirisako T, Takao T, et al. A ubiquitin-like system mediates protein lipidation. Nature 2000;408:488-92.
15. Mizushima N, Yamamoto A, Hatano M, et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001;152:657-68.
16. Tanida I, Tanida-Miyake E, Ueno T, et al. The human homolog of Saccharomyces cerevisiae Apg7p is a protein-activating enzyme for multiple substrates including human Apgl2p, GATE-16, GA-BARAP, and MAP-LC3. J Biol Chem 2001;276:1701-6.
17. Hanada T, Ohsumi Y Structure-function relationship of Atgl2, a ubiquitin-like modifier essential for autophagy. Autophagy 2005; 1: 110-8.
18. Mizushima N, Noda T, Ohsumi Y Apgl6p is required for the function of the Apg 12p-Apg5p conjugate in the yeast autophagy pathway. Embo J 1999;18:3888-96.
19. Kuma A, Mizushima N, Ishihara N, et al. Formation of the approximately 350-kDa Apgl2-Apg5.Apgl6 multimeric complex, mediated by Apgl6 oligomerization, is essential for autophagy in yeast. J Biol Chem 2002;277:18619-25.
20. Abeliovich H, Dunn WA Jr, Kim J, et al. Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol 2000;151:1025-34.
21. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macro-autophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 2006;281:29776-87.
22. Boya P, Gonzalez-Polo RA, Casares N, et al. Inhibition of macro-autophagy triggers apoptosis. Mol Cell Biol 2005;25:1025-40.
23. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39:596-604.
24. Petiot A, Ogier-Denis E, Blommaart EF, et al. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275:992-8.
25. Lee SB, Kim S, Lee J, et al. ATG1, an autophagy regulator, inhibits cell growth by negatively regulating S6 kinase. EMBO Rep 2007;8:360-5.
26. Neufeld TP Contribution of Atgl-dependent autophagy to TOR-mediated cell growth and survival. Autophagy 2007;3:477-9.
27. Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell 2000;103:253-62.
28. Hartford CM, Ratain MJ. Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin Pharmacol Ther 2007;82:381-8.
29. Rao RD, Buckner JC, Sarkaria JN. Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents. Curr Cancer Drug Targets 2004;4:621-35.
30. Easton JB, Houghton PJ. mTOR and cancer therapy. Oncogene 2006;25:6436-46.
31. Kamada Y, Funakoshi T, Shintani T, et al. Tor-mediated induction of autophagy via an Apgl protein kinase complex. J Cell Biol 2000;150:1507-13.
32. Webber JL, Young AR, Tooze SA. Atg9 trafficking in Mammalian cells. Autophagy 2007;3:54-6.
33. Young AR, Chan EY, Hu XW, et al. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J Cell Sci 2006;119:3888-900.
34. Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 2006;119:259-70.
35. Furuya N, Yu J, Byfield M, et al. The evolutionary conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 2005;1:46-52.
36. Aoki H, Iwado E, Eller MS, et al. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. Faseb J 2007;21:2918-30.
37. Yokoyama T, Kondo Y, Kondo S. Roles of mTOR and STAT3 in autophagy induced by telomere 3' overhang-specific DNA oligonucleotides. Autophagy 2007;3:496-8.
38. Djavaheri-Mergny M, Codogno P. Autophagy joins the game to regulate NF-kappaB signaling pathways. CellRes 2007;17:576-7.
39. Qing G, Yan P, Qu Z, et al. Hsp90 regulates processing of NF-kappaB2 p100 involving protection of NF-kappaB-inducing kinase (NIK) from autophagy-mediated degradation. Cell Res 2007;17:520-30.
40. Qing G, Yan P, Xiao G. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK). Cell Res 2006;16:895-901.
41. Djavaheri-Mergny M, Amelotti M, Mathieu J, et al. NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 2006;281:30373-82.
42. Fabre C, Carvalho G, Tasdemir E, et al. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodys-plastic syndrome and acute myeloid leukemia. Oncogene 2007;26:4071-83.
43. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005;122: 927-39.
44. Sakon S, Xue X, Takekawa M, et al. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. Embo J 2003;22:3898-909.
45. Djavaheri-Mergny M, Amelotti M, Mathieu J, et al. Regulation of autophagy by NF-kappaB transcription factor and reactives oxygen species. Autophagy 2007;3:390-2.
46. Yu L, Wan F, Dutta S, et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci U S A 2006; 103: 4952-4957.
47. Yue Z, Jin S, Yang C, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003;100:15077-82.
48. Maria Fimia G, Stoykova A, Romagnoli A, et al. Ambral regulates autophagy and development of the nervous system. Nature 2007;447:1121-5.
49. Mizushima N, Yamamoto A, Matsui M, et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004;15:1101-11.
50. Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-6.
51. Scherz-Shouval R, Shvets E, Fass E, et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. Embo J 2007;26:1749-60.
52. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 2007;17:422-7.
53. Yorimitsu T, Nair U, Yang Z, et al. Endoplasmic reticulum stress triggers autophagy. J Biol Chem 2006;281:30299-304.
54. Rodriguez-Enriquez S, Kim I, Currin RT, et al. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy 2006;2:39-46.
55. Yousefi S, Perozzo R, Schmid I, et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006;8:1124-32.
56. Maiuri MC, Le Toumelin G, Criollo A, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. Embo J 2007;26:2527-39.
57. Luo S, Rubinsztein DC. Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ 2007;14:1247-50.
58. Debnath J, Baehrecke EH, Kroemer G. Does autophagy contribute to cell death? Autophagy 2005;1:66-74.
59. Bialik S, Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu Rev Biochem 2006;75:189-210.
60. Pyo JO, Jang MH, Kwon YK, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 2005;280: 20722-9.
61. Deretic V. Autophagy as an immune defense mechanism. Curr Opin Immunol 2006;18:375-82.
62. Munz C. Autophagy and antigen presentation. Cell Microbiol 2006;8:891-8.
63. Chaplin DD. Overview of the human immune response. J Allergy Clin Immunol 2006;117 (2 Suppl Mini-Primer):S430-5.
64. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005;23:975-1028.
65. Nimmerjahn F, Milosevic S, Behrends U, et al. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur J Immunol 2003;33:1250-9.
66. Paludan C, Schmid D, Landthaler M, et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005;307:593-6.
67. Strawbridge AB, Blum JS. Autophagy in MHC class II antigen processing. Curr Opin Immunol 2007;19:87-92.
68. Brazil MI, Weiss S, Stockinger B. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur J Immunol 1997;27:1506-14.
69. Munz C, Bickham KL, Subklewe M, et al. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med 2000;191:1649-60.
70. Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007;26:79-92.
71. Lee HK, Lund JM, Ramanathan B, et al. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007; 315:1398-401.
72. Dubuisson JF, Swanson MS. Mouse infection by Legionella, a model to analyze autophagy. Autophagy 2006;2:179-82.
73. Xu Y, Jagannath C, Liu XD, et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007; 27:135-44.
74. Birmingham CL, Smith AC, Bakowski MA, et al. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem 2006;281:11374-83.
75. Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004;119:753-66.
76. Singh SB, Davis AS, Taylor GA, et al. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006;313:1438-41.
77. Cossart P, Sansonetti PJ. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004;304:242-8.
78. Ogawa M, Yoshimori T, Suzuki T, et al. Escape of intracellular Shigella from autophagy. Science 2005;307:727-31.
79. Colombo MI. Autophagy: a pathogen driven process. IUBMB Life 2007;59:238-42.
80. Suzuki T, Franchi L, Toma C, et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog 2007;3:elll.
81. Pizarro-Cerda J, Meresse S, Partom RG, et al. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Im-mun 1998;66:5711-24.
82. Amer AO, Swanson MS. Autophagy is an immediate macrophage response to Legionella pneumophila. Cell Microbiol 2005;7:765-78.
83. Gutierrez MG, Saka HA, Chinen I, et al. Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc Natl Acad Sci USA 2007; 104:1829-34.
84. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34.
85. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-40.
86. Cummings JR, Cooney R, Pathan S, et al. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Inflamm Bowel Dis 2007;13:941-6.
87. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007;39:207-11.
88. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007;39:830-2.
89. Prescott NJ, Fisher SA, Franke A, et al. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 2007;132:1665-71.
90. Baldassano RN, Bradfield JP, Monos DS, et al. Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut 2007;56:1171-3.
91. Altshuler D, Daly M. Guilt beyond a reasonable doubt. Nat Genet 2007;39:813-5.
92. Yamazaki K, Onouchi Y, Takazoe M, et al. Association analysis of genetic variants in IL23R, ATG16L1 and 5pl3. 1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007;52:575-83.
93. Perlmutter DH. Liver injury in alphal-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest 2002;110:1579-83.
94. Lomas DA, Evans DL, Finch JT, et al. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992;357:605-7.
95. Perlmutter DH. The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins. Autophagy 2006;2:258-63.
96. Kamimoto T, Shoji S, Hidvegi T, et al. Intracellular inclusions containing mutant alphal-antitrypsin Z are propagated in the absence of autophagic activity. J Biol Chem 2006;281:4467-76.
97. Perlmutter DH. Alphal-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum. Methods Mol Biol 2003;232:39-56.
98. Teckman JH, Perlmutter DH. Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 2000; 279:G961-74.
99. Kruse KB, Brodsky JL, McCracken AA. Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (AlPiZ) and another for aggregates of AlPiZ. Mol Biol Cell 2006;17:203-12.
100. Teckman JH, An JK, Loethen S, et al. Fasting in alphal-antitrypsin deficient liver: constitutive [correction of consultative] activation of autophagy. Am J Physiol Gastrointest Liver Physiol 2002; 283:G1156-65.
101. Teckman JH, An JK, Blomenkamp K, et al. Mitochondrial autophagy and injury in the liver in alpha 1 -antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol 2004;286:G851-62.
102. Erlich S, Shohami E, Pinkas-Kramarski R. Neurodegeneration induces upregulation of Beclin 1. Autophagy 2006;2:49-51.
103. Qin ZH, Wang Y, Kegel KB, et al. Autophagy regulates the processing of amino terminal huntington fragments. Hum Mol Genet 2003;12:3231-44.
104. Sarkar S, Perlstein EO, Imarisio S, et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007;3:331-8.
105. Rubinsztein DC, DiFiglia M, Heintz N, et al. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005;1:11-22.
106. Ventruti A, Cuervo AM. Autophagy and neurodegeneration. Curr Neurol Neurosci Rep 2007;7:443-51.
107. Carstea ED, Morris JA, Coleman KG, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 1997;277:228-31.
108. Pacheco CD, Lieberman AP Lipid trafficking defects increase beclin-1 and activate autophagy in Niemann-Pick type C disease. Autophagy 2007;3:487-9.
109. Pacheco CD, Kunkel R, Lieberman AP. Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects. Hum Mol Genet 2007;16:1495-503.
110. Heikoop JC, van den Berg M, Strijland A, et al. Turnover of peroxisomal vesicles by autophagic proteolysis in cultured fibroblasts from Zellweger patients. Eur J Cell Biol 1992;57:165-71.
111. Phillips AD, Schmitz J. Familial microvillous atrophy: a clinico-pathological survey of 23 cases. J Pediatr Gastroenterol Nutr 1992;14:380-96.
112. Phillips AD, Jenkins P. Congenital microvillous atrophy: specific diagnostic features. Arch Dis Child 1985;60:135-40.
113. Reinshagen K, Nairn HY, Zimmer KP Autophagocytosis of the apical membrane in microvillus inclusion disease. Gut 2002; 51:514-21.
114. Cutz E, Rhoads JM, Drumm B, et al. Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med 1989;320:646-51.
115. Sato T, Mushiake S, Kato Y, et al. The Rab8 GTPase regulates apical protein localization in intestinal cells. Nature 2007;448:366-9.
116. Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy 2007;3:28-31.
117. Gauthier NC, Monzo P, Gonzalez T, et al. Early endosomes associated with dynamic F-actin structures are required for late trafficking of H. pylori VacA toxin. J Cell Biol 2007;177:343-54.
118. Hait WN, Jin S, Yang JM. A matter of life or death (or both): understanding autophagy in cancer. Clin Cancer Res 2006; 12 (7 Pt l):1961-5.
119. Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005;5:726-34.
120. Liang C, Feng P, Ku B, et al. Autophagic and tumour suppressor activity of a novel Beclinl-binding protein UVRAG. Nat Cell Biol 2006;8:688-99.
121. Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999;402:672-6.
122. Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003;112:1809-20.
123. Liang C, Feng P, Ku B, et al. UVRAG: a new player in autophagy and tumor cell growth. Autophagy 2007;3:69-71.
124. Lang SA, Gaumann A, Koehl GE, et al. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer 2007; 120:1803-10.
125. Mosley JD, Poirier JT, Seachrist DD, et al. Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer. Mol Cancer Ther 2007;6:2188-97.
126. Crighton D, Wilkinson S, O'Prey J, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006;126:121-34.
127. Carew JS, Nawrocki ST, Cleveland JL. Modulating autophagy for therapeutic benefit. Autophagy 2007;3:464-7.
128. Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 2005;65:3336-46.
129. Aggarwal S, Ichikawa H, Takada Y, et al. Curcumin (diferuloyl-methane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 2006;69:195-206.
130. Aoki H, Takada Y, Kondo S, et al. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 2007; 72:29-39.